Navigation Links
Raptor Pharmaceuticals Provides Update of Product Programs
Date:9/13/2007

these forward-looking statements. Factors which may significantly change or prevent the Company's forward looking statements from fruition include that the Company may be unsuccessful in developing any products; that its technology may not be validated as the Company progresses further and its methods may not be accepted by the scientific community; that the Company is unable to retain or attract key employees whose knowledge is essential to the development of its products; that unforeseen scientific difficulties develop with the Company's process; that the Company's patents are not sufficient to protect essential aspects of its technology; that competitors may invent better technology; that the Company's products may not work as well as hoped or worse, that the Company's products may harm recipients; and that the Company may not be able to raise sufficient funds for development or working capital when required. As well, the Company's products may never develop into useful products and even if they do, they may not be approved for sale to the public. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in the Company's filings from time to time with the Securities and Exchange Commission ("SEC"), which we strongly urge you to read and consider, including the Company's Registration Statement on Form SB-2, as amended, that was declared effective on July 10, 2006, the Company's annual report on Form 10- KSB and Form 10-KSB/A filed with the SEC on November 22, 2006, and January 18, 2007, respectively, and the Company's quarterly report Form 10-QSB filed with the SEC on June 29, 2007, all of which are available free of charge on the SEC's web site at http://www.sec.gov.

Subsequent written and oral forward-looking statements attributable to t
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Kan. , July 25, 2014 /PRNewswire-iReach/ -- ... and TCGRx, of Powers Lake, Wisconsin ... partners in a distribution and co-marketing agreement allowing ... retail pharmacies throughout the United States ... robotics-based pharmacy management and workflow systems to retail ...
(Date:7/25/2014)... , July 25, 2014  CVS Caremark Corporation (NYSE: ... call on Tuesday, August 5, 2014, at 8:30 a.m. ... quarter 2014 financial results. An audio webcast ... the Investor Relations portion of the CVS Caremark website ... http://info.cvscaremark.com/investors . This webcast will be archived and ...
(Date:7/25/2014)... Trinidad and Tobago , July 25, 2014 ... the Trinidad & Tobago Ministry of Health approved ... therapy that significantly increases the cure rate from ... infected with the genotype 1 virus. Telaprevir is ... the trade brand INCIVO®. Photo - ...
Breaking Medicine Technology:ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... The University of Oxford Clinical Trial,Service Unit ... results of the SEAS trial of ezetimibe should ... the SHARP and,IMPROVE-IT trials of ezetimibe, and reporting ... independently of the drug,manufacturers., The two hypothesis-testing ...
... clinicians identify risk in patients, including ... BIRMINGHAM, Ala., July 21 Using the ... link between,adiponectin and heart disease progression. The information ... cholesterol and heart,disease risk-lowering treatments in at-risk patients., ...
Cached Medicine Technology:Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 2Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 3VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3
(Date:7/25/2014)... (HealthDay News) -- Shift workers, especially men, may be at ... on such schedules, a new study suggests. Also at ... set schedule, with shifts moving around at various times of ... said one expert, Dr. Alan Manevitz, a clinical psychiatrist at ... long known that working shifts disrupts many key body chemicals, ...
(Date:7/25/2014)... The American Society of Anesthesiologists (ASA) today announced ... (PSH) Learning Collaborative, a national initiative designed to ... surgery. More than 40 leading health care ... the collaborative, which will convene for the first ... July 25-26, in Schaumburg, Ill. , The PSH ...
(Date:7/25/2014)... 25, 2014 In today’s technological era, ... and supporting devices. This benefits the organization in various ... cyber attacks which can destroy the confidential information and ... Risk and Compliance (EGRC) manage and protect the enterprise ... can cause loss in dollars to the comp may. ...
(Date:7/25/2014)... Dallas, TX (PRWEB) July 25, 2014 ... Market Outlook to 2020” provides company shares and ... categories, and global corporate-level profiles of the key ... related to the Laryngoscopes market wherever available. , ... dynamic market forecast models. Rsearcher uses epidemiology and ...
(Date:7/25/2014)... A protein that controls when genes are switched on ... of the brain to regulate metabolism, UT Southwestern Medical ... to new therapies to treat obesity and diabetes, since ... 1 (Xbp1s) appears to influence the body,s sensitivity ... hormones central to the body,s regulation of food intake ...
Breaking Medicine News(10 mins):Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:ASA launches national Perioperative Surgical Home learning collaborative 2Health News:ASA launches national Perioperative Surgical Home learning collaborative 3Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 2Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 3Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 4Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 5Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2
... for Seven Water Bodies; New Species, Water Body Added , ... fish consumption advisories that include two new fish species and ... list, but also eases or lifts advisories on fish from ... an interagency partnership between the Pennsylvania Fish and Boat Commission ...
... ... to serve more effectively millions of people suffering from alcohol abuse worldwide.....read more... ... ... has completely redesigned its website to serve more effectively millions of people suffering ...
... ... its highly acclaimed Restore® program, which provides immediate support and practical advice to family ... ... Alcohol Recovery (NIFAR®) is introducing a new version of its highly acclaimed Restore® ...
... sooner, with no fasting, , TUESDAY, Dec. 29 (HealthDay News) ... Diabetes Association is promoting a more prominent role for the ... diabetes and prediabetes. , Long used in the management of ... for the previous two to three months. The new guidelines ...
... , Health gurus say recommit each Monday until the habit ... January 1st millions of Americans will resolve to quit smoking -- again. ... Johns Hopkins and the American Cancer Society say it doesn,t have to ... agree, just quit again the following Monday. And recommit to stay quit ...
... 29 Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), ... a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system ... today provided a business update, and management reiterated its ... Echo completes the development and regulatory review of its ...
Cached Medicine News:Health News:Updated Fish Consumption Advisories Issued for 2010 2Health News:Updated Fish Consumption Advisories Issued for 2010 3Health News:New NIFAR Website Offers Millions a Comprehensive Resource for Alcohol Education, Recovery, and Support 2Health News:New NIFAR Website Offers Millions a Comprehensive Resource for Alcohol Education, Recovery, and Support 3Health News:Innovative Program Gives Instant Support to Millions who are Living and Suffering with a Problem Drinker 2Health News:Innovative Program Gives Instant Support to Millions who are Living and Suffering with a Problem Drinker 3Health News:New Guidelines Urge A1C Test for Diabetes Diagnosis 2Health News:This New Years, Smokers Get 52 Chances to Stay Quit 2Health News:Echo Therapeutics Provides Business Update 2Health News:Echo Therapeutics Provides Business Update 3Health News:Echo Therapeutics Provides Business Update 4Health News:Echo Therapeutics Provides Business Update 5
... Mapping. Biosense Webster offers a complete ... SANTORO Fixed Catheter is designed for ... the coronary sinus. The pair of ... tip permit pacing in the coronary ...
Standard Deflectable Catheters...
... Soft HIS diagnostic catheters provide ... designed curve that allows for ... HIS bundle. In addition, the ... reduce the risk of perforation ...
The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures....
Medicine Products: